Cetrorelix
- Generic Name
- Cetrorelix
- Brand Names
- Cetrotide
- Drug Type
- Small Molecule
- Chemical Formula
- C70H92ClN17O14
- CAS Number
- 120287-85-6
- Unique Ingredient Identifier
- OON1HFZ4BA
- Background
Cetrorelix is a man-made hormone that blocks the effects of Gonadotropin Releasing Hormone (GnRH). GnRH controls another hormone that is called luteinizing hormone (LH), which is the hormone that starts ovulation during the menstrual cycle. When undergoing hormone treatment sometimes premature ovulation can occur, leading to eggs that are not ready for fertilization to be released. Cetrorelix does not allow the premature release of these eggs to occur.
- Indication
For the inhibition of premature LH surges in women undergoing controlled ovarian stimulation
- Associated Conditions
- -
- Associated Therapies
- Controlled Ovarian Stimulation
Clinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer
- First Posted Date
- 2008-03-04
- Last Posted Date
- 2008-03-04
- Lead Sponsor
- Nippon Kayaku Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT00628121
- Locations
- 🇯🇵
Kitasato University East Hospital, Sagamihara, Kanagawa, Japan
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
- Conditions
- Endometriosis
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2008-03-31
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00244452
- Locations
- 🇷🇴
Site 4007, Bucuresti, Romania
🇷🇴Site 4005, Bucuresti, Romania
🇺🇦Site 3803, Kiev, Ukraine
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.